Erythorbic acid

Erythorbic Acid (E315 / Isoascorbic Acid)

Identity and Chemical Characterization

Erythorbic acid is a six-carbon carbohydrate acid whose systematic chemical names include D-araboascorbic acid, D-isoascorbic acid, and isoascorbic acid. It is a stereoisomer — specifically the C5 epimer — of ascorbic acid (vitamin C). Its molecular formula is C₆H₈O₆, identical to that of ascorbic acid, and it shares the same γ-lactone ring structure, differing only in the spatial orientation of the hydroxyl group at the fifth carbon. The two compounds carry different CAS registry numbers, and the American Chemical Society does not consider one to fall under the identity of the other.

Erythorbic acid is denoted by the E number E315 and is widely used as an antioxidant in processed foods. Its sodium salt, sodium erythorbate (E316), is the form most commonly encountered in commercial meat-curing applications. Sodium erythorbate is the sodium salt of erythorbic acid and is itself a stereoisomer of sodium ascorbate. Additional derivatives that have been described include potassium erythorbate, calcium erythorbate, and several ester forms such as erythorbic acid palmitate. Documented derivatives include erythorbic acid, sodium erythorbate, potassium erythorbate, calcium erythorbate, erythorbic acid phosphoric acid ester, erythorbic acid sulfuric acid ester, and erythorbic acid palmitic acid ester, among others.

Natural Occurrence

Erythorbic acid is not entirely synthetic in origin. It is a natural product found in Flammulina velutipes, Hypsizygus marmoreus, and other organisms. Historically, it was also identified in certain plant tissues and in the urine of animals administered precursor compounds. It was identified in cress seedlings in D-altrono-γ-lactone solution and in the urine of rats injected with D-mannono-γ-lactone. A strain of Penicillium isolated from soil was shown to produce D-araboascorbic acid (erythorbic acid) from D-glucose, D-gluconic acid, and sucrose. However, its natural concentrations in foods are negligible, and virtually all erythorbic acid in the commercial food supply is produced synthetically.

Physical and Chemical Properties

Erythorbic acid appears as a white to slightly yellowish crystalline powder that is highly soluble in water. The decomposition temperature of erythorbic acid is 164–172 °C, making it stable during heat-processing of foods. In its dry, crystalline state it is relatively non-reactive, but when in solution in water it reacts readily with atmospheric oxygen and other oxidizing agents, making it a valuable antioxidant.

Relationship to Vitamin C

Erythorbic acid is a stereoisomer of L-ascorbic acid and is used as an antioxidant in foods and oral pharmaceutical formulations, but it has approximately 5% of the vitamin C activity of L-ascorbic acid. Studies show that natural and synthetic ascorbic acid behave similarly in biological systems, whereas stereoisomers of ascorbic acid show a decreased anti-ascorbutic activity in comparison — a clear indication that the materials are functionally different in metabolic systems, at least in degree. Both forms of ascorbate are equally effective antioxidants and control free radical reactions in several ways. Erythorbic acid is considerably less expensive compared to L-ascorbic acid and therefore is commonly used as an antioxidant additive in food.

Historical Background and Development

Discovery and First Synthesis (1933)

Erythorbic acid was first synthesized in 1933 by the German chemists Kurt Maurer and Bruno Schiedt. They achieved this by reacting methyl 2-keto-D-gluconate with sodium methoxide, producing a compound with a chemical structure closely resembling ascorbic acid but differing at the C5 position. This synthesis was motivated by the recent isolation of vitamin C in 1932 and aimed to create a cost-effective analog with comparable reducing capabilities for potential industrial applications.

During the 1930s, early research emphasized erythorbic acid's antioxidant properties, demonstrating its ability to inhibit oxidation in various chemical systems through strong reducing action similar to ascorbic acid. Studies confirmed its efficacy in preventing rancidity in fats and oils, positioning it as a promising preservative. Research established that it was estimated to be only one-twentieth as effective as ascorbic acid as a vitamin C source and is not capable of preventing scurvy, but it nevertheless possesses strong oxygen-reducing characteristics which make it ideal for industrial application due to its ease of production.

Natural Production Discovered

The finding that erythorbic acid occurred naturally was confirmed when researchers documented its production by certain fungal species. Researchers became the first to report on the production of D-araboascorbic acid from Penicillium, which was important since it showed that erythorbate was indeed a naturally occurring product.

Industrial-Scale Production and Regulatory History

Erythorbic acid is very easily produced by fermentation, being obtainable in just one step compared to ascorbic acid's two. A number of Penicillium species naturally produce this chemical from glucose. This is the original process developed in the 1960s, but it had low volumetric efficiency and glucose yield compared to the modern method. Today the industrial process is quite similar to the Reichstein process used for ascorbic acid, only chirally flipped. Microbial fermentation first produces a 2-keto-sugar acid — for example, by Pseudomonas fluorescens AR4 converting glucose to 2-keto-D-gluconate — and then chemical rearrangement produces the final product.

Sodium erythorbate gained prominence in the food industry during the mid-20th century, particularly in the 1970s, as a safer alternative to ascorbic acid in meat curing to accelerate color development and inhibit the formation of carcinogenic nitrosamines when used with nitrites. Since the FDA banned the use of sulfites as a preservative on raw fruits and vegetables from 1986, the use of erythorbic acid has increased. In the European Union, erythorbic acid (E315) was more recently approved for food use, with restrictions initially limiting its application to semi-preserved and preserved meat, fish, and crustacean products. Isoascorbic or erythorbic acid is a stereoisomer of ascorbic acid acting as a preservative against oxidation and decoloration, and was recently approved for food use in the European market.

Key Constituents, Chemical Forms, and Preparations

The commercially relevant forms of erythorbic acid used in food processing include:

• Erythorbic acid (free acid, E315): The parent compound, used as a direct antioxidant additive in baked goods, beverages, fruit products, and vegetables. In the United States, erythorbic acid is widely used as a food additive in many processed food items, including baked goods, fruit and water ices, meat and meat products, vegetables and vegetable juices, candy, and non-alcoholic beverages.
• Sodium erythorbate (E316): Sodium erythorbate is used primarily to bring out a nice red color in sausage, ham, bacon, and other cured meat products or fish products, as it can accelerate the reduction of nitrite and nitrate to nitric oxide, which generates the pink colour in meat.
• Fatty acid esters (e.g., erythorbic acid palmitate): Erythorbic acid 6-fatty acid esters, which possess higher fat solubility with retained reducing power, are preferred when exploiting the antioxidant property with foods of high fat content. These esters are additionally used as emulsion stabilizers in food preparations.

Erythorbic acid is used in over a thousand cosmetic formulations at low concentrations; ascorbyl palmitate is used at concentrations between 0.01 and 0.2%, and erythorbic acid is used at concentrations of 0.5–1%.

Traditional and Historical Uses

Unlike many natural ingredients covered in botanical medicine traditions, erythorbic acid has no documented history in pre-modern herbal or dietary medicine. It is entirely a product of twentieth-century industrial chemistry and food science. Its "traditional" use, in the relevant historical sense, is as a food-technology ingredient rather than as a medicinal preparation.

The practice that erythorbic acid was designed to support — curing meats with nitrite or nitrate salts — does have ancient roots. The cured meats in the human diet have a history of thousands of years. However, the deliberate addition of erythorbic acid or its salts to this process emerged only after the compound's synthesis in 1933 and commercial production in the mid-twentieth century. Its adoption was driven by regulatory, public-health, and cost considerations rather than by any traditional medical theory.

Mechanisms of Action

Oxygen Scavenging (Primary Antioxidant Mechanism)

The antioxidative mechanism of erythorbic acid — the same as that of sodium erythorbate and ascorbic acid — is as an oxygen scavenger that reacts with oxygen to reduce the oxygen content in food. This is mechanistically distinct from lipid-soluble antioxidants (such as butylated hydroxytoluene), which function through radical chain termination. Ascorbates are potent free radical scavengers; in this process of controlling free radicals, ascorbate is oxidized (losing electrons) to a form that can be readily reduced back to L-ascorbic acid by another antioxidant such as alpha-tocopherol (vitamin E). Because neither erythorbic acid's iron-reducing nor its iron-chelating activity is mediated by an enzyme, which would otherwise confer some chiral selectivity, the compound can exert these effects despite its different stereochemical configuration relative to L-ascorbic acid.

Nitrite Reduction and Nitrosamine Inhibition in Cured Meats

One of the most practically important mechanisms of erythorbic acid and its sodium salt in food processing is the acceleration of nitrite conversion to nitric oxide, and the consequent reduction in nitrosamine formation. Nitrous acid can decompose to generate nitrosating species, which in turn react with amines to form nitrosamines. To prevent this, antioxidants such as ascorbate and erythorbate are added to meat formulations; these compounds inhibit nitrosamine formation by reducing HNO₂ to nitric oxide (NO), a far less reactive and non-nitrosating species. This protective mechanism is especially relevant during cooking, when heat and moisture promote nitrite degradation and potential nitrosation reactions.

Much like ascorbic acid, erythorbic acid increases nitrosylation of the central iron atom of muscle myoglobin, resulting in the formation of reddish-brown nitrosomyoglobin and the characteristic pink color of nitrosohemochrome or nitrosyl-heme upon cooking. Again, like ascorbic acid, it reduces the formation of nitrosamines. By reducing the amount of nitrites used in meat products and their residual levels, erythorbate effectively reduces the formation of nitrosamines, which are carcinogens. The USDA has codified this principle: 0.055% of either sodium ascorbate or sodium erythorbate is required in pumped bacon, and this addition greatly reduces the amount of free nitrite and thus minimizes the formation of nitrosamines.

However, it should be noted that antioxidants such as ascorbate and erythorbic acid are polar and their effect on oxidative processes in the lipid phase of meat may therefore be limited.

Iron Reduction and Chelation (Non-Heme Iron Absorption)

Erythorbic acid is a potent enhancer of non-heme iron absorption, just like ascorbate. This is thought to be due to it exerting the same iron-reducing and iron-chelating activity as ascorbic acid. Because these reactions are not enzyme-mediated (and hence not chirally selective), erythorbic acid can reduce ferric iron (Fe³⁺) to the more soluble and absorbable ferrous iron (Fe²⁺) regardless of its different stereochemistry relative to vitamin C.

Free Radical Scavenging Synergism

The combined antioxidant effect of ascorbate and tocopherol is greater than the sum of the two, and they are said to act synergistically. Ascorbate and tocopherol are often used in combination as antioxidant additives in food because they effectively inhibit free radical reactions in both aqueous and lipid environments. Erythorbic acid, being functionally equivalent to ascorbate as a free radical scavenger in the aqueous phase, participates in comparable synergistic chemistry when co-administered with lipid-soluble antioxidants.

Scientific Evidence by Area of Use

1. Non-Heme Iron Absorption Enhancement

The most robust human clinical evidence for a physiological role of erythorbic acid relates to its capacity to enhance dietary non-heme iron absorption.

The key study is a clinical trial published in The American Journal of Clinical Nutrition in 2004 (Fidler MC, Davidsson L, Zeder C, Hurrell RF; PMID 14684404). The aims of the study were to evaluate the effect of erythorbic acid on iron absorption from ferrous sulfate at molar ratios of 2:1 and 4:1 (relative to iron) and to compare the effect of erythorbic acid directly with that of ascorbic acid. The results showed that erythorbic acid is a potent enhancer of iron absorption from ferrous sulfate. Specifically, it was found to be twice as effective as ascorbic acid in enhancing non-heme iron absorption. The mechanistic explanation proposed is that, like ascorbic acid, erythorbic acid exerts the same iron-reducing and iron-chelating activity as ascorbic acid, and neither of these reactions is mediated by an enzyme that would confer chiral selectivity.

The public health significance of this finding is considerable. Americans are estimated to ingest 200 mg of erythorbic acid per day, making it a very important factor in understanding iron absorption. In the United States, intake from processed foods may reach 200 mg/d, and erythorbic acid intake could be as high as, if not higher than, ascorbic acid intake. Although it has little vitamin C activity, its enhancing effect on iron absorption appears to be almost double that of ascorbic acid. Authors of a review in The American Journal of Clinical Nutrition concluded that the abundance of such compounds in the American diet might help explain why it has not been possible to demonstrate clearly the enhancing effect of vitamin C on iron absorption in multiple-meal studies of self-selected diets.

The results of the 2004 study suggest that dietary intake of erythorbic acid should be taken into account when estimating dietary iron bioavailability. The influence of erythorbic acid on iron absorption would be expected to be of lesser importance in the European Union and Switzerland, because legislation in those countries restricts the use of erythorbic acid to semi-preserved and preserved meat, fish, and crustacean products; consequently, intake of erythorbic acid in Western European countries would be associated with animal tissue and would therefore be expected to have a limited influence on dietary non-heme iron absorption.

The role of widely consumed food additives such as erythorbic acid on iron bioavailability from mixed diets nonetheless needs further clarification. Evidence strength: moderate (one well-conducted human clinical trial, mechanistically coherent, significant public health implications).

2. Effects on Vitamin C (Ascorbic Acid) Metabolism

A clinical trial by Sauberlich HE, Tamura T, Craig CB, Freeberg LE, and Liu T, published in The American Journal of Clinical Nutrition in 1996 (PMID 8780343), directly investigated whether erythorbic acid interferes with or supports vitamin C status in humans.

Erythorbic acid is used in the United States as a food additive. Studies were conducted to determine whether the ingestion of erythorbic acid in the diet had any beneficial or adverse effects on the human requirement for vitamin C. Young women were fed diets that contained controlled amounts of erythorbic acid and ascorbic acid. In pharmacokinetic evaluations, erythorbic acid and ascorbic acid were rapidly absorbed with little interaction. Erythorbic acid cleared from the body more rapidly than ascorbic acid. Some subjects received diets deficient in vitamin C for periods of up to 30 days. Increasing intakes of erythorbic acid, or prolonged intakes of up to 1 g erythorbic acid per day, did not indicate any interactions with ascorbic acid.

Consumption of erythorbic acid resulted in the presence of erythorbic acid in mononuclear leukocytes. Ascorbic acid concentrations in these cells were not affected by the presence of erythorbic acid. Erythorbic acid disappeared quickly from these cells with cessation of erythorbic acid supplements. Prolonged ingestion of erythorbic acid by young women neither antagonized nor spared their vitamin C status.

A second related study investigated ascorbic acid metabolism in eleven non-pregnant adult women who were maintained in a metabolic unit and fed a formula diet devoid of ascorbic acid for 54 days. After depletion for 24 days, the subjects received increasing supplements of ascorbic acid in the presence or absence of 600 mg/d of erythorbic acid. Erythorbic acid did not present any adverse effects, but rather had a small sparing effect on ascorbic acid status.

The key mechanistic nuance is that erythorbic acid appears to be a much poorer substrate for the same (sodium-dependent active) transport system as ascorbic acid and may thus act as a weak competitive inhibitor of L-ascorbate uptake. However, based on the clinical trial evidence, this theoretical interaction does not appear to produce a practically significant effect on vitamin C status at habitual dietary exposure levels. Evidence strength: moderate (controlled human metabolic study; findings were clearly negative for harm and positive for safety).

3. Nitrosamine Reduction in Processed Meats

The addition of erythorbic acid and sodium erythorbate to nitrite-cured meats to reduce nitrosamine formation is well-supported by mechanistic and experimental data, and has been codified in regulatory requirements. Concerns about the formation of N-nitrosamines — a class of potent carcinogens — have long shaped regulatory and technical strategies in the processing of cured meats. These compounds can form under certain conditions when nitrite, used as a preservative and colour-fixing agent, interacts with secondary amines during cooking or digestion. However, the risk of N-nitrosamine formation in the human stomach has been significantly reduced when modern curing and cooking practices are followed.

The reduction of nitrous acid to nitric oxide by erythorbate/ascorbate inhibits nitrosamine formation and this protective mechanism is especially relevant during cooking, when heat and moisture promote nitrite degradation and potential nitrosation reactions. Evidence strength: well-established mechanistically and in food science; regulatory bodies in the United States and European Union have formalized erythorbate use on this basis.

4. Use as a Food Preservative: Lipid Oxidation and Color Stabilization

Erythorbic acid is widely used to stabilize color, reduce nitrate uses, and prevent oxidation in meat products, fruits, and vegetables. It maintains color and flavor and extends shelf life. These effects are attributable to its oxygen-scavenging activity in aqueous systems. The practical limitation of this activity is that, as noted above, erythorbic acid, being polar, has limited effect on oxidative processes in the lipid phase of meat. Evidence strength: well-established in food-science literature; not a therapeutic claim.

Body Systems and Health Areas Associated with Erythorbic Acid

Hematological System: Iron Metabolism and Bioavailability

The most clinically relevant physiological association of erythorbic acid at habitual dietary exposures relates to iron metabolism. It has been estimated that the average diet can provide as much as 200 mg erythorbic acid per day, which would be expected to markedly influence dietary non-heme iron absorption, and consequently erythorbic acid could have long-term effects on iron status. This means that erythorbic acid — introduced into the diet as a food additive rather than as a supplement — may be a significant and previously underappreciated driver of iron status in populations consuming high amounts of processed foods.

Gastrointestinal System: Absorption and Transport

Erythorbic acid is readily absorbed and metabolized. Following an oral dose of 500 mg of erythorbic acid to human subjects, the blood level curves for ascorbic acid and erythorbic acid showed a similar rise. Mechanistically, erythorbic acid appears to be a much poorer substrate for the sodium-dependent active transport system for ascorbic acid and may thus act as a weak competitive inhibitor of L-ascorbate uptake. However, as confirmed by clinical study, this interaction is not significant at typical intake levels.

Immune/Cellular System: Leukocyte Uptake

The 1996 clinical trial documented that consumption of erythorbic acid resulted in its presence in mononuclear leukocytes. Ascorbic acid concentrations in these cells were not affected by the presence of erythorbic acid. Erythorbic acid disappeared quickly from these cells with cessation of erythorbic acid supplements. The biological significance of erythorbic acid accumulation in leukocytes — a compartment important for ascorbic acid's immune functions — has not been further investigated in human trials.

Cancer Prevention (Indirect): Nitrosamine Suppression

The inhibition of carcinogenic N-nitrosamine formation in cured meats and in the gastrointestinal tract by erythorbate represents an indirect, mechanistically plausible association with cancer risk reduction. Like ascorbic acid, erythorbic acid reduces the formation of nitrosamines. This effect is well-documented at the mechanistic level. No long-term interventional studies in humans have directly assessed whether dietary erythorbate exposure reduces cancer incidence, and such a claim would be speculative on the basis of current evidence.

Dosage Forms and Dosages Reported in Studies

• Oral dose (pharmacokinetic study): Following an oral dose of 500 mg of erythorbic acid to human subjects, the blood level curves for ascorbic acid and erythorbic acid showed a similar rise.
• Oral dose (renal excretion study): In five human subjects, an oral dose of 300 mg was shown to have no effect on urinary excretion of ascorbic acid.
• Controlled dietary study (vitamin C metabolism): Prolonged intakes of up to 1 g erythorbic acid per day did not indicate any interactions with ascorbic acid.
• Metabolic unit study (ascorbic acid depletion-repletion): In the study of ascorbic acid metabolism in non-pregnant women, erythorbic acid was administered at 600 mg/d alongside increasing supplements of ascorbic acid.
• Iron absorption trial (molar ratios): The iron absorption study evaluated erythorbic acid at molar ratios of 2:1 and 4:1 relative to iron.
• Meat processing (USDA regulatory dose): According to USDA, 0.055% of either sodium ascorbate or sodium erythorbate is required in pumped bacon.
• Meat processing (general industry norm): Sodium ascorbate, ascorbic acid, sodium erythorbate, and erythorbic acid are commonly used antioxidants for meat products; it is common to add 500 mg per kg to meat products.
• Cosmetic formulations: Erythorbic acid is used at concentrations of 0.5–1% in cosmetic products.

Regulatory Status

The safety of erythorbic acid as a food additive has been approved by the U.S. Food and Drug Administration (FDA), European Food Safety Authority (EFSA), the Joint FAO/WHO Expert Committee on Food Additives (JECFA), as well as other authorities. It is generally recognized as safe (GRAS) when used in accordance with good manufacturing practices in food and feed.

It can be used as an antimicrobial agent, antioxidant, color or coloring adjunct, curing or pickling agent, flavor enhancer, and flavoring agent or adjuvant. Erythorbic acid (E315) is listed in Commission Regulation (EU) No 231/2012 as an authorized food additive in the EU as an "additive other than colours and sweeteners."

The use of these food additives was evaluated by the Scientific Committee on Food (SCF), which established an acceptable daily intake (ADI) of 6 mg/kg body weight per day. JECFA, in its latest evaluation, established an ADI "not specified" for erythorbic acid. The two bodies therefore arrived at different formal ADI expressions, with JECFA's "not specified" designation indicating that the totality of available evidence did not support a safety concern at likely intake levels.

Safety Considerations and Interactions

Formal Toxicological Assessment (EFSA 2016)

The most comprehensive regulatory toxicological review of erythorbic acid was published in 2016, when the EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS) re-evaluated the substance:

• Acute toxicity: The Panel noted that the acute toxicity of erythorbic acid or sodium erythorbate is low.
• Subchronic toxicity: There was no indication of adverse effects from the available subchronic toxicity studies.
• Genotoxicity: There is no concern with respect to genotoxicity.
• Carcinogenicity: There is no concern with respect to carcinogenicity. This is consistent with animal research: sodium erythorbate is not carcinogenic in F344 rats.
• No observed adverse effect level (NOAEL): The Panel identified a NOAEL of 650 mg/kg body weight per day, based on a decrease in body weight from a carcinogenicity study.
• Reproductive and developmental toxicity: No maternal and developmental effects were observed from a prenatal developmental toxicity study with sodium erythorbate.
• Overall conclusion: After studies of genotoxicity and carcinogenicity and others, EFSA concluded "there is no reason to revise the current ADI of 6 mg/kg bw/day and the use of erythorbic acid (E315) and sodium erythorbate (E316) as food additives at the permitted or reported use and use levels would not be of safety concern."
• Limitation of the database: The Panel recognized the limitation of the overall toxicological database (no reproductive and chronic toxicity studies), but did not consider it necessary to increase the usual uncertainty factor of 100 in deriving an ADI.

Interaction with Vitamin C Status

As documented in the Sauberlich et al. (1996) clinical trial, prolonged ingestion of erythorbic acid by young women neither antagonized nor spared their vitamin C status. While erythorbic acid may theoretically compete with ascorbic acid at the intestinal sodium-dependent transport system, this has not been shown to impair vitamin C status in controlled clinical settings even at doses up to 1 g per day.

Potential Concern: Iron Overload in Susceptible Individuals

The potent iron-absorption-enhancing effect of erythorbic acid — approximately double that of ascorbic acid at comparable molar levels — raises a theoretically important safety concern for individuals with iron-loading disorders such as hereditary hemochromatosis. Erythorbic acid at habitual dietary exposure levels of up to 200 mg/d could have long-term effects on iron status. Individuals with conditions associated with iron overload who consume large amounts of processed foods preserved with erythorbate should be aware of this interaction, although dedicated clinical trials have not specifically examined this subpopulation.

Analytical Interference with Plasma Vitamin C Measurements

A pharmacologically important practical consideration is that erythorbic acid, when present in blood, can interfere with standard colorimetric assays used to measure plasma ascorbic acid concentrations. This can cause falsely elevated apparent vitamin C levels in individuals who have ingested erythorbic acid, potentially confounding clinical assessments of vitamin C nutritional status. This has been documented in the literature (Sauberlich et al., 1996).

Lack of Vitamin C (Antiscorbutic) Activity

Despite structural similarity to ascorbic acid, erythorbic acid cannot prevent or treat scurvy. D-Erythorbic acid is an epimer of L-ascorbic acid but lacks antiscorbutic activity. Foods fortified with or preserved by erythorbic acid therefore do not provide a meaningful source of vitamin C activity. Ascorbyl palmitate has vitamin C activity approximately equal to that of L-ascorbic acid, whereas erythorbic acid has only 5% activity.

General Safety Profile

The acute toxicity of erythorbic acid or sodium erythorbate is low; there was no indication of adverse effects from the available subchronic toxicity studies; there is no concern with respect to their genotoxicity nor to carcinogenicity. Considering that the ADI is not exceeded by any population group, the Panel also concluded that the use of erythorbic acid (E315) and sodium erythorbate (E316) as food additives at the permitted or reported use and use levels would not be of safety concern.

Summary of Evidence Gaps

Despite many decades of widespread use, several important knowledge gaps remain:

• There are no reproductive and chronic toxicity studies available in the EFSA-reviewed database, which the EFSA Panel acknowledged as a limitation.
• The role of widely consumed food additives such as erythorbic acid on iron bioavailability from mixed diets needs clarification.
• No long-term human randomized controlled trials have assessed the effects of habitual erythorbic acid exposure on iron stores, anemia incidence, or hemochromatosis progression.
• The clinical significance of erythorbic acid's accumulation in leukocytes, and whether it supports or interferes with immune-relevant functions of ascorbic acid, has not been studied.
• There are no clinical supplement trials evaluating erythorbic acid as a standalone dietary supplement in human therapeutic settings; its evidence base derives from food-additive research rather than clinical nutrition intervention.

References

• PubChem — Erythorbic Acid (CID 54675810)
• Fidler MC, Davidsson L, Zeder C, Hurrell RF. Erythorbic acid is a potent enhancer of nonheme-iron absorption. Am J Clin Nutr. 2004;79(1):99–102. (ScienceDirect)
• Sauberlich HE, Tamura T, Craig CB, Freeberg LE, Liu T. Effects of erythorbic acid on vitamin C metabolism in young women. Am J Clin Nutr. 1996;64(3):336–346. (ScienceDirect)
• Influence of dietary intakes of erythorbic acid on plasma vitamin C analyses. PubMed PMID 1962590
• EFSA Panel on Food Additives and Nutrient Sources (ANS). Scientific Opinion on the re-evaluation of erythorbic acid (E315) and sodium erythorbate (E316) as food additives. EFSA Journal. 2016;14(1):4360.
• EFSA — Scientific Opinion on E315 and E316 (official EFSA page)
• WHO/JECFA. Erythorbic acid and its sodium salt. WHO Food Additives Series 28 (1991)
• Iron bioavailability and dietary reference values. Am J Clin Nutr. (review citing erythorbic acid iron-absorption data)
• Wikipedia — Erythorbic Acid (for historical and synthesis overview)
• NCATS Inxight Drugs — Erythorbic Acid
• Andersen FA. Final Report on the Safety Assessment of Ascorbyl Palmitate, Ascorbyl Dipalmitate, Ascorbyl Stearate, Erythorbic Acid, and Sodium Erythorbate. International Journal of Toxicology. 1999;18(Suppl 3):1–26.
• ScienceDirect Topics — Isoascorbic Acid (overview of antioxidant chemistry)
• Innovation in sodium erythorbate production: the use of membrane-reactors. PubMed PMID 11381548
• ResearchGate — EFSA Scientific Opinion PDF on E315/E316 re-evaluation
• FAO GSFA Online — Erythorbic Acid (Isoascorbic acid) (315)
• Earthworm Express — On the Mitigation of N-Nitrosamine Formation in Cured Meats: The Role of Ascorbate, Erythorbate, and Other Antioxidants
• Herrmann SS. N-nitrosamines in processed meat products (PhD Thesis, DTU Food)
• Ascorbic acid and erythorbic acid metabolism in nonpregnant women. ScienceDirect
• Organic Materials Review Institute (OMRI) — Erythorbic Acid